Charles Schwab Investment Management Inc. Grows Stock Position in Integer Holdings Co. (NYSE:ITGR)

Charles Schwab Investment Management Inc. grew its position in Integer Holdings Co. (NYSE:ITGR) by 1.2% during the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 404,029 shares of the medical equipment provider’s stock after acquiring an additional 4,946 shares during the quarter. Charles Schwab Investment Management Inc. owned about 1.20% of Integer worth $52,524,000 as of its most recent SEC filing.

Several other large investors have also recently made changes to their positions in the company. Contravisory Investment Management Inc. boosted its stake in Integer by 55.9% during the 3rd quarter. Contravisory Investment Management Inc. now owns 223 shares of the medical equipment provider’s stock worth $29,000 after purchasing an additional 80 shares during the last quarter. Xponance Inc. lifted its stake in shares of Integer by 4.9% in the second quarter. Xponance Inc. now owns 2,112 shares of the medical equipment provider’s stock worth $245,000 after buying an additional 99 shares in the last quarter. Azzad Asset Management Inc. ADV boosted its position in Integer by 0.9% during the third quarter. Azzad Asset Management Inc. ADV now owns 11,572 shares of the medical equipment provider’s stock worth $1,504,000 after acquiring an additional 107 shares during the last quarter. GAMMA Investing LLC grew its stake in Integer by 60.9% during the 2nd quarter. GAMMA Investing LLC now owns 375 shares of the medical equipment provider’s stock valued at $43,000 after acquiring an additional 142 shares in the last quarter. Finally, Envestnet Portfolio Solutions Inc. raised its holdings in Integer by 3.6% in the 2nd quarter. Envestnet Portfolio Solutions Inc. now owns 5,948 shares of the medical equipment provider’s stock valued at $689,000 after acquiring an additional 205 shares during the last quarter. 99.29% of the stock is currently owned by hedge funds and other institutional investors.

Integer Stock Down 0.2 %

Shares of NYSE:ITGR opened at $140.50 on Friday. The business has a 50-day moving average price of $131.38 and a 200 day moving average price of $124.45. Integer Holdings Co. has a 12-month low of $84.75 and a 12-month high of $142.00. The company has a current ratio of 3.28, a quick ratio of 2.09 and a debt-to-equity ratio of 0.67. The company has a market capitalization of $4.71 billion, a price-to-earnings ratio of 43.36, a PEG ratio of 2.02 and a beta of 1.09.

Integer (NYSE:ITGR) last released its quarterly earnings results on Thursday, October 24th. The medical equipment provider reported $1.43 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.36 by $0.07. Integer had a net margin of 6.70% and a return on equity of 11.63%. The business had revenue of $431.42 million for the quarter, compared to the consensus estimate of $440.59 million. During the same period in the previous year, the firm earned $1.27 EPS. The business’s revenue was up 8.7% on a year-over-year basis. Sell-side analysts expect that Integer Holdings Co. will post 5.34 EPS for the current year.

Wall Street Analyst Weigh In

ITGR has been the topic of several recent research reports. Bank of America boosted their target price on Integer from $135.00 to $145.00 and gave the stock a “buy” rating in a report on Tuesday, October 1st. Piper Sandler reissued an “overweight” rating and set a $140.00 price objective (up previously from $125.00) on shares of Integer in a research note on Friday, October 25th. Benchmark raised their target price on Integer from $130.00 to $140.00 and gave the stock a “buy” rating in a research note on Monday, October 21st. Truist Financial lowered their price target on shares of Integer from $150.00 to $147.00 and set a “buy” rating on the stock in a research report on Friday, October 25th. Finally, Citigroup raised their price objective on shares of Integer from $124.00 to $130.00 and gave the stock a “neutral” rating in a research report on Tuesday, October 1st. One equities research analyst has rated the stock with a hold rating and seven have assigned a buy rating to the company. According to MarketBeat, Integer currently has a consensus rating of “Moderate Buy” and an average target price of $139.75.

Integer Company Profile

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.